Skip to main content

VDAC3 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 6 and 1 bp insertion in exon 6.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (AB266066), expandable thumbnail
  • Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (AB266066), expandable thumbnail

Key facts

Cell type
HEK-293T
Species or organism
Human
Tissue
Kidney
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 6 and 1 bp insertion in exon 6

Alternative names

Recommended products

VDAC3 KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 6 and 1 bp insertion in exon 6.

Key facts

Cell type
HEK-293T
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 6 and 1 bp insertion in exon 6
Concentration
Loading...

Properties

Gene name
VDAC3
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium
DMEM (High Glucose) + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

Voltage-dependent anion channel 3 (VDAC3) also known as porin 3 has a molecular mass of approximately 32 kDa. It is a part of the voltage-dependent anion channel family located in the outer mitochondrial membrane. VDAC3 plays a role in regulating the passage of ions and metabolites across the mitochondrial membrane. This channel shares a similar structure with other VDAC isoforms and is expressed in several tissues with high levels found in the heart and skeletal muscle.

Biological function summary

VDAC3 contributes to cellular energy homeostasis and the exchange of ions and small metabolites between mitochondria and cytoplasm. VDAC3 may participate in a complex with other mitochondrial proteins affecting the mitochondrial permeability transition pore (mPTP). The precise regulation of VDAC3 ensures normal mitochondrial function which is critical for maintaining cellular metabolism and programming cell death including apoptotic pathways.

Pathways

VDAC3 is involved in apoptotic regulation and energy metabolism. Its activity impacts the intrinsic pathway of apoptosis where it interacts with Bcl-2 family proteins such as Bax and Bak influencing cytochrome c release. VDAC3's role in these pathways connects it to overall cellular stress responses and energy balance. Additionally VDAC3 coordinates with other VDAC isoforms to ensure mitochondrial integrity under variable physiological conditions.

Associated diseases and disorders

VDAC3's malfunction links to neurodegenerative diseases and cardiac disorders. Dysfunction in VDAC3 has associations with diseases like Alzheimer's due to its involvement in mitochondrial dysfunction. Additionally its influence on apoptotic pathways implicates VDAC3 in heart diseases where improper apoptosis can lead to cardiac tissue damage. In these contexts VDAC3 interacts with the protein amyloid-beta in Alzheimer's and with caspases in cardiac conditions suggesting its importance in disease mechanisms.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (ab266066), expandable thumbnail

    Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (ab266066)

    Allele-1: 16 bp deletion in exon 6

  • Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (ab266066), expandable thumbnail

    Sanger Sequencing - Human VDAC3 knockout HEK-293T cell line (ab266066)

    Allele-2: 1 bp insertion in exon 6.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com